1. Home
  2. GSM vs GHRS Comparison

GSM vs GHRS Comparison

Compare GSM & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.67

Market Cap

782.0M

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$12.97

Market Cap

892.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSM
GHRS
Founded
2015
2018
Country
United Kingdom
Ireland
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.0M
892.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GSM
GHRS
Price
$4.67
$12.97
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$6.00
$30.11
AVG Volume (30 Days)
1.3M
235.2K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
1.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,373,244,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$6.72
52 Week High
$5.74
$20.50

Technical Indicators

Market Signals
Indicator
GSM
GHRS
Relative Strength Index (RSI) 55.52 42.27
Support Level $4.39 $12.04
Resistance Level $4.77 $13.15
Average True Range (ATR) 0.18 0.86
MACD 0.02 -0.21
Stochastic Oscillator 68.75 24.35

Price Performance

Historical Comparison
GSM
GHRS

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: